iBio DSO Ratio 2011-2026 | IBIO

Annual DSO Ratio iBio

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	138	38.6	1.25 K	17.5	61.7	162	233	87.7	365	365	100	241

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.25 K	17.5	255

Quarterly DSO Ratio iBio

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	28.3	86.4	344	463	36.1	31.1	41.7	9.71	33.3	43.5	72.7	28.2	106	19.2	197	10.5	123	118	163	58.1	247	119	221	589	232	232	264	303	293	72.6	11.4	51	67.5	-	-	-	-	-	86.7	82.1	68.4	108	94.6	134	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
589	9.71	136

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Apellis Pharmaceuticals APLS	115	$ 19.87	-1.44 %	$ 2.51 B	USA
Aptorum Group Limited APM	20.6	$ 0.82	3.61 %	$ 4.47 M	China
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
AbCellera Biologics ABCL	173	$ 3.66	-1.43 %	$ 1.09 B	Canada
Athersys ATHX	22.6	-	3.77 %	$ 22.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
AVEO Pharmaceuticals AVEO	47.5	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	105	$ 163.94	-0.07 %	$ 8.16 B	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
BridgeBio Pharma BBIO	52.4	$ 65.12	0.91 %	$ 12.5 B	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
BioMarin Pharmaceutical BMRN	88.9	$ 59.06	0.91 %	$ 11.3 B	USA
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	164	-	-16.75 %	$ 25.8 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
CTI BioPharma Corp. CTIC	52.1	-	-	$ 1.2 B	USA
Cyclacel Pharmaceuticals CYCC	81.5 K	-	-5.98 %	$ 34.1 M	USA
Cyclacel Pharmaceuticals CYCCP	3.66 K	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	60.8	-	-	$ 2.18 B	USA
Capricor Therapeutics CAPR	31.9	$ 25.35	-1.92 %	$ 679 M	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Codexis CDXS	32.9	$ 0.97	-1.14 %	$ 71.2 M	USA
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Certara CERT	89.6	$ 7.44	2.69 %	$ 1.19 B	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Coherus BioSciences CHRS	263	$ 1.71	3.33 %	$ 161 M	USA
Evofem Biosciences EVFM	68.8	-	7.55 %	$ 38.1 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA